GMED Globus Medical Inc - Class A

  1. Stocks
  2. Healthcare
  3. NYSE: GMED

Price (delayed)

$80.84

Market cap

$10.97B

P/E Ratio

18.58

Dividend/share

N/A

EPS

$4.35

Enterprise value

$10.53B

?
Relative Growth: Rel. Growth: 99
Relative Strength: Rel. Strength: 55
Relative Valuation: Rel. Valuation: 83
Relative Profitability: Rel. Profitability: 94

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
The P/E is 69% less than the 5-year quarterly average of 59.0 and 12% less than the last 4 quarters average of 20.6
The gross profit has grown by 38% YoY and by 6% from the previous quarter
The debt has increased by 25% year-on-year but it has declined by 2.9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.globusmedical.com
Peers: SYK OFIX ATEC

Key stats

What are the main financial stats of GMED

GMED stock price

How has the Globus Medical Inc - Class A stock price performed over time
Intraday
2.6%
1 week
3.31%
1 month
0.9%
1 year
53.57%
YTD
-7.41%
QTD
2.32%

Financial performance

How have Globus Medical Inc - Class A's revenue and profit performed over time
Revenue
$3.1B
Gross profit
$2.1B
Operating income
$533.2M
Net income
$586.71M
Gross margin
67.9%
Net margin
18.9%
The net margin has surged by 155% year-on-year and by 3.3% since the previous quarter
The operating income has soared by 109% YoY and by 11% QoQ
The company's operating margin has surged by 69% YoY and by 6% QoQ
The gross profit has grown by 38% YoY and by 6% from the previous quarter

Price vs fundamentals

How does GMED's price correlate with its fundamentals

Growth

What is Globus Medical Inc - Class A's growth rate over time

Valuation

What is Globus Medical Inc - Class A stock price valuation
GMED P/E details
P/E
18.58
P/B
2.31
P/S
3.53
EV/EBIT
16.26
EV/EBITDA
11.34
EV/Sales
3.4
The P/E is 69% less than the 5-year quarterly average of 59.0 and 12% less than the last 4 quarters average of 20.6
The EPS has grown by 9% since the previous quarter
The stock's P/B is 20% less than its 5-year quarterly average of 2.8 but 2.3% more than its last 4 quarters average of 2.2
GMED's equity is up by 16% year-on-year and by 3.5% since the previous quarter
GMED's P/S is 31% lower than its 5-year quarterly average of 5.0
Globus Medical Inc - Class A's revenue has increased by 23% YoY and by 6% QoQ

Efficiency

How efficient is Globus Medical Inc - Class A business performance
Globus Medical Inc - Class A's return on equity has surged by 183% YoY and by 4.8% QoQ
GMED's ROIC has soared by 136% year-on-year
The return on sales has surged by 125% year-on-year and by 3% since the previous quarter
The ROA is up by 6% since the previous quarter

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical Inc - Class A financials performed over time
GMED's total assets is up by 15% year-on-year and by 2.6% since the previous quarter
The company's total liabilities rose by 14% YoY but it fell by 3.1% QoQ
The debt is 98% smaller than the equity
The company's debt to equity fell by 33% QoQ
The debt has increased by 25% year-on-year but it has declined by 2.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.